View Post

Jemperli

In Clinical Studies News by Barbara Jacoby

From: breastcancer.org Jemperli (chemical name: dostarlimab-gxly) is approved by the U.S. Food and Drug Administration (FDA) to treat mismatch repair deficient (dMMR) advanced-stage breast cancer that has grown during or after treatment if no other treatment options are available. Jemperli also is approved to treat dMMR advanced-stage endometrial cancer that has grown after treatment with platinum chemotherapy. How Jemperli works …

View Post

Breast Surgeons Demonstrate Accuracy of New Technology for Marking Location of Cancerous Lymph Nodes

In Clinical Studies News by Barbara Jacoby

Source: Hackensack Meridian Health From: trendkite.com Findings Also Make Procedure More Comfortable for Patients  Breast surgeons at Hackensack Meridian Hackensack University Medical Center have a new tool that allows them to pinpoint breast tumors more easily, with many benefits to the patient. The reflector device has proven useful as an alternative to wire localization for locating breast tumors before lumpectomy. …

View Post

Many clinical trials for new cancer drugs didn’t include any data on race

In Clinical Studies News by Barbara Jacoby

By: Megan Thielking From: statnews.com One-third of the clinical trials that led to new cancer drugs approved between 2008 and 2018 didn’t report on the race of trial participants — and even studies that did report on race often had far fewer black and Hispanic cancer patients than might be expected, given the makeup of the cancer patient population.That’s according …

Home test a new option for colon cancer screening

In In The News by Barbara Jacoby

From: cbsnews.com Colon cancer is the second leading cause of cancer deaths in the United States, but it doesn’t have to be. Now, a new, non-invasive home test for colon cancer will make screening more accessible to the millions of people who have avoided it. Colonoscopy is recommended once every 10 years for adults over the age of 50. However, …